-
1
-
-
84876804736
-
The global distribution and burden of dengue
-
Bhatt, S. et al. The global distribution and burden of dengue. Nature 496, 504-507 (2013).
-
(2013)
Nature
, vol.496
, pp. 504-507
-
-
Bhatt, S.1
-
2
-
-
84861830178
-
The economic burden of dengue
-
Gubler, D. J. The economic burden of dengue. Am. J. Trop. Med. Hyg. 86, 743-744 (2012).
-
(2012)
Am. J. Trop. Med. Hyg.
, vol.86
, pp. 743-744
-
-
Gubler, D.J.1
-
3
-
-
2142827156
-
Dengue: Defining protective versus pathologic immunity
-
Rothman, A. L. Dengue: defining protective versus pathologic immunity. J. Clin. Invest. 113, 946-951 (2004).
-
(2004)
J. Clin. Invest.
, vol.113
, pp. 946-951
-
-
Rothman, A.L.1
-
4
-
-
0018580825
-
Vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody
-
Halstead, S. B. In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody. J. Infect. Dis. 140, 527-533 (1979).
-
(1979)
J. Infect. Dis.
, vol.140
, pp. 527-533
-
-
Halstead, S.B.1
-
5
-
-
0018636837
-
Antibody-mediated enhancement of Flavivirus replication in macrophage-like cell lines
-
Peiris, J. S. & Porterfield, J. S. Antibody-mediated enhancement of Flavivirus replication in macrophage-like cell lines. Nature 282, 509-511 (1979).
-
(1979)
Nature
, vol.282
, pp. 509-511
-
-
Peiris, J.S.1
Porterfield, J.S.2
-
6
-
-
0019831472
-
Monoclonal anti-Fc receptor IgG blocks antibody enhancement of viral replication in macrophages
-
Peiris, J. S., Gordon, S., Unkeless, J. C. & Porterfield, J. S. Monoclonal anti-Fc receptor IgG blocks antibody enhancement of viral replication in macrophages. Nature 289, 189-191 (1981).
-
(1981)
Nature
, vol.289
, pp. 189-191
-
-
Peiris, J.S.1
Gordon, S.2
Unkeless, J.C.3
Porterfield, J.S.4
-
7
-
-
84908160975
-
Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: A phase 3, randomised, observer-masked, placebo-controlled trial
-
Capeding, M. R. et al. Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial. Lancet 384, 1358-1365 (2014).
-
(2014)
Lancet
, vol.384
, pp. 1358-1365
-
-
Capeding, M.R.1
-
8
-
-
84920585186
-
Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America
-
Villar, L. et al. Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America. N. Engl. J. Med. 372, 113-123 (2014).
-
(2014)
N. Engl. J. Med.
, vol.372
, pp. 113-123
-
-
Villar, L.1
-
9
-
-
84868211668
-
Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: A randomised, controlled phase 2b trial
-
Sabchareon, A. et al. Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial. Lancet 380, 1559-1567 (2012).
-
(2012)
Lancet
, vol.380
, pp. 1559-1567
-
-
Sabchareon, A.1
-
10
-
-
0033052643
-
Dengue virus structural differences that correlate with pathogenesis
-
Leitmeyer, K. C. et al. Dengue virus structural differences that correlate with pathogenesis. J. Virol. 73, 4738-4747 (1999).
-
(1999)
J. Virol.
, vol.73
, pp. 4738-4747
-
-
Leitmeyer, K.C.1
-
11
-
-
0023135329
-
Monoclonal antibodies against dengue 2 virus E-glycoprotein protect mice against lethal dengue infection
-
Kaufman, B. M., Summers, P. L., Dubois, D. R. & Eckels, K. H. Monoclonal antibodies against dengue 2 virus E-glycoprotein protect mice against lethal dengue infection. Am. J. Trop. Med. Hyg. 36, 427-434 (1987).
-
(1987)
Am. J. Trop. Med. Hyg.
, vol.36
, pp. 427-434
-
-
Kaufman, B.M.1
Summers, P.L.2
Dubois, D.R.3
Eckels, K.H.4
-
12
-
-
36349025356
-
Epitope determinants of a chimpanzee dengue virus type 4 (DENV-4)-neutralizing antibody and protection against DENV-4 challenge in mice and rhesus monkeys by passively transferred humanized antibody
-
Lai, C. J. et al. Epitope determinants of a chimpanzee dengue virus type 4 (DENV-4)-neutralizing antibody and protection against DENV-4 challenge in mice and rhesus monkeys by passively transferred humanized antibody. J. Virol. 81, 12766-12774 (2007).
-
(2007)
J. Virol.
, vol.81
, pp. 12766-12774
-
-
Lai, C.J.1
-
13
-
-
53249134451
-
Antibodies play a greater role than immune cells in heterologous protection against secondary dengue virus infection in a mouse model
-
Kyle, J. L., Balsitis, S. J., Zhang, L., Beatty, P. R. & Harris, E. Antibodies play a greater role than immune cells in heterologous protection against secondary dengue virus infection in a mouse model. Virology 380, 296-303 (2008).
-
(2008)
Virology
, vol.380
, pp. 296-303
-
-
Kyle, J.L.1
Balsitis, S.J.2
Zhang, L.3
Beatty, P.R.4
Harris, E.5
-
14
-
-
77956605864
-
The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity
-
Beltramello, M. et al. The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity. Cell Host Microbe 8, 271-283 (2010).
-
(2010)
Cell Host Microbe
, vol.8
, pp. 271-283
-
-
Beltramello, M.1
-
15
-
-
77956031215
-
Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2
-
Sukupolvi-Petty, S. et al. Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2. J. Virol. 84, 9227-9239 (2010).
-
(2010)
J. Virol.
, vol.84
, pp. 9227-9239
-
-
Sukupolvi-Petty, S.1
-
16
-
-
77954039828
-
The development of therapeutic antibodies that neutralize homologous and heterologous genotypes of dengue virus type 1
-
Shrestha, B. et al. The development of therapeutic antibodies that neutralize homologous and heterologous genotypes of dengue virus type 1. PLoS Pathog. 6, e1000823 (2010).
-
(2010)
PLoS Pathog.
, vol.6
, pp. e1000823
-
-
Shrestha, B.1
-
17
-
-
68349150945
-
Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeys
-
Johnson, P. R. et al. Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeys. Nat. Med. 15, 901-906 (2009).
-
(2009)
Nat. Med.
, vol.15
, pp. 901-906
-
-
Johnson, P.R.1
-
18
-
-
84855466746
-
Antibody-based protection against HIV infection by vectored immunoprophylaxis
-
Balazs, A. B. et al. Antibody-based protection against HIV infection by vectored immunoprophylaxis. Nature 481, 81-84 (2012).
-
(2012)
Nature
, vol.481
, pp. 81-84
-
-
Balazs, A.B.1
-
19
-
-
84896120124
-
Vectored immunoprophylaxis protects humanized mice from mucosal HIV transmission
-
Balazs, A. B. et al. Vectored immunoprophylaxis protects humanized mice from mucosal HIV transmission. Nat. Med. 20, 296-300 (2014).
-
(2014)
Nat. Med.
, vol.20
, pp. 296-300
-
-
Balazs, A.B.1
-
20
-
-
84880520936
-
Intranasal antibody gene transfer in mice and ferrets elicits broad protection against pandemic influenza
-
Limberis, M. P. et al. Intranasal antibody gene transfer in mice and ferrets elicits broad protection against pandemic influenza. Sci. Transl. Med. 5, 187ra172 (2013).
-
(2013)
Sci. Transl. Med.
, vol.5
, pp. 187ra172
-
-
Limberis, M.P.1
-
21
-
-
84888603787
-
Vectored expression of the broadly neutralizing antibody FI6 in mouse airway provides partial protection against a new avian influenza A virus, H7N9
-
Limberis, M. P. et al. Vectored expression of the broadly neutralizing antibody FI6 in mouse airway provides partial protection against a new avian influenza A virus, H7N9. Clin. Vaccine Immunol. 20, 1836-1837 (2013).
-
(2013)
Clin. Vaccine Immunol.
, vol.20
, pp. 1836-1837
-
-
Limberis, M.P.1
-
22
-
-
84880296945
-
Broad protection against influenza infection by vectored immunoprophylaxis in mice
-
Balazs, A. B., Bloom, J. D., Hong, C. M., Rao, D. S. & Baltimore, D. Broad protection against influenza infection by vectored immunoprophylaxis in mice. Nat. Biotechnol. 31, 647-652 (2013).
-
(2013)
Nat. Biotechnol.
, vol.31
, pp. 647-652
-
-
Balazs, A.B.1
Bloom, J.D.2
Hong, C.M.3
Rao, D.S.4
Baltimore, D.5
-
23
-
-
0033966668
-
Safety and immune responses to a DNA-based human immunodeficiency virus (HIV) type i env/rev vaccine in HIV-infected recipients: Follow-up data
-
MacGregor, R. R., Boyer, J. D., Ciccarelli, R. B., Ginsberg, R. S. & Weiner, D. B. Safety and immune responses to a DNA-based human immunodeficiency virus (HIV) type I env/rev vaccine in HIV-infected recipients: follow-up data. J. Infect. Dis. 181, 406 (2000).
-
(2000)
J. Infect. Dis.
, vol.181
, pp. 406
-
-
MacGregor, R.R.1
Boyer, J.D.2
Ciccarelli, R.B.3
Ginsberg, R.S.4
Weiner, D.B.5
-
24
-
-
0034575448
-
DNA vaccines: Capacity to induce auto-immunity and tolerance
-
Klinman, D. M. et al. DNA vaccines: capacity to induce auto-immunity and tolerance. Dev. Biol. (Basel) 104, 45-51 (2000).
-
(2000)
Dev. Biol. (Basel)
, vol.104
, pp. 45-51
-
-
Klinman, D.M.1
-
25
-
-
52449104809
-
DNA vaccines: Ready for prime time? Nat
-
Kutzler, M. A. & Weiner, D. B. DNA vaccines: ready for prime time? Nat. Rev. Genet. 9, 776-788 (2008).
-
(2008)
Rev. Genet.
, vol.9
, pp. 776-788
-
-
Kutzler, M.A.1
Weiner, D.B.2
-
26
-
-
84885155143
-
Optimized and enhanced DNA plasmid vector based in vivo construction of a neutralizing anti-HIV-1 envelope glycoprotein Fab
-
Muthumani, K. et al. Optimized and enhanced DNA plasmid vector based in vivo construction of a neutralizing anti-HIV-1 envelope glycoprotein Fab. Hum. Vaccin. Immunother. 9, 2253-2262 (2013).
-
(2013)
Hum. Vaccin. Immunother.
, vol.9
, pp. 2253-2262
-
-
Muthumani, K.1
-
27
-
-
1642443440
-
Monoclonal antibodies produced by muscle after plasmid injection and electroporation
-
Tjelle, T. E. et al. Monoclonal antibodies produced by muscle after plasmid injection and electroporation. Mol. Ther. 9, 328-336 (2004).
-
(2004)
Mol. Ther.
, vol.9
, pp. 328-336
-
-
Tjelle, T.E.1
-
28
-
-
79957781340
-
Electroporation delivery of DNA vaccines: Prospects for success
-
Sardesai, N. Y. & Weiner, D. B. Electroporation delivery of DNA vaccines: prospects for success. Curr. Opin. Immunol. 23, 421-429 (2011).
-
(2011)
Curr. Opin. Immunol.
, vol.23
, pp. 421-429
-
-
Sardesai, N.Y.1
Weiner, D.B.2
-
29
-
-
34548496893
-
Fc receptor but not complement binding is important in antibody protection against HIV
-
Hessell, A. J. et al. Fc receptor but not complement binding is important in antibody protection against HIV. Nature 449, 101-104 (2007).
-
(2007)
Nature
, vol.449
, pp. 101-104
-
-
Hessell, A.J.1
-
30
-
-
76249103868
-
Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease
-
Zellweger, R. M., Prestwood, T. R. & Shresta, S. Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease. Cell Host Microbe 7, 128-139 (2010).
-
(2010)
Cell Host Microbe
, vol.7
, pp. 128-139
-
-
Zellweger, R.M.1
Prestwood, T.R.2
Shresta, S.3
-
31
-
-
33749467342
-
Murine model for dengue virus-induced lethal disease with increased vascular permeability
-
Shresta, S., Sharar, K. L., Prigozhin, D. M., Beatty, P. R. & Harris, E. Murine model for dengue virus-induced lethal disease with increased vascular permeability. J. Virol. 80, 10208-10217 (2006).
-
(2006)
J. Virol.
, vol.80
, pp. 10208-10217
-
-
Shresta, S.1
Sharar, K.L.2
Prigozhin, D.M.3
Beatty, P.R.4
Harris, E.5
-
32
-
-
0036132847
-
Effects of antigen and genetic adjuvants on immune responses to human immunodeficiency virus DNA vaccines in mice
-
Moore, A. C., Kong, W. P., Chakrabarti, B. K. & Nabel, G. J. Effects of antigen and genetic adjuvants on immune responses to human immunodeficiency virus DNA vaccines in mice. J. Virol. 76, 243-250 (2002).
-
(2002)
J. Virol.
, vol.76
, pp. 243-250
-
-
Moore, A.C.1
Kong, W.P.2
Chakrabarti, B.K.3
Nabel, G.J.4
-
33
-
-
84896540059
-
Alarmin IL-33 acts as an immunoadjuvant to enhance antigen-specific tumor immunity
-
Villarreal, D. O. et al. Alarmin IL-33 acts as an immunoadjuvant to enhance antigen-specific tumor immunity. Cancer Res. 74, 1789-1800 (2014).
-
(2014)
Cancer Res.
, vol.74
, pp. 1789-1800
-
-
Villarreal, D.O.1
-
34
-
-
84876701903
-
Dengue virus: Isolation, propagation, quantification, and storage
-
Medina, F. et al. Dengue virus: isolation, propagation, quantification, and storage. Curr. Protoc. Microbiol. 27, 15D. 2. 1-15D. 2. 24 (2012).
-
(2012)
Curr. Protoc. Microbiol.
, vol.27
, pp. 15D21-15D224
-
-
Medina, F.1
|